메뉴 건너뛰기




Volumn 51, Issue 18, 2008, Pages 1803-1817

The Year in Hypertension

Author keywords

[No Author keywords available]

Indexed keywords

ALAGEBRIUM; ALISKIREN; AMILORIDE; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GUANYLATE CYCLASE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; LISINOPRIL; LOSARTAN; PERINDOPRIL; PLACEBO; PROPRANOLOL; RENIN INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VALSARTAN;

EID: 42949127526     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.03.010     Document Type: Review
Times cited : (17)

References (115)
  • 1
    • 33749544190 scopus 로고    scopus 로고
    • The year in hypertension
    • Williams B. The year in hypertension. J Am Coll Cardiol 48 (2006) 1698-1711
    • (2006) J Am Coll Cardiol , vol.48 , pp. 1698-1711
    • Williams, B.1
  • 2
    • 34247547816 scopus 로고    scopus 로고
    • Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk
    • Kikuya M., Hansen T.W., Thijs L., et al. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 115 (2007) 2145-2152
    • (2007) Circulation , vol.115 , pp. 2145-2152
    • Kikuya, M.1    Hansen, T.W.2    Thijs, L.3
  • 3
    • 34250371289 scopus 로고    scopus 로고
    • Which measurement of home blood pressure should be used for clinical evaluation when multiple measurements are made?
    • Kawabe H., and Saito I. Which measurement of home blood pressure should be used for clinical evaluation when multiple measurements are made?. J Hypertens 25 (2007) 1369-1374
    • (2007) J Hypertens , vol.25 , pp. 1369-1374
    • Kawabe, H.1    Saito, I.2
  • 4
    • 34250308759 scopus 로고    scopus 로고
    • Home blood pressure monitoring in clinical practice: how many measurements and when?
    • Padfield P.L., and Parati G. Home blood pressure monitoring in clinical practice: how many measurements and when?. J Hypertens 25 (2007) 1337-1339
    • (2007) J Hypertens , vol.25 , pp. 1337-1339
    • Padfield, P.L.1    Parati, G.2
  • 5
    • 12444277817 scopus 로고    scopus 로고
    • European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement
    • O'Brien E., O'Brien E., Asmar R., et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 21 (2003) 821-848
    • (2003) J Hypertens , vol.21 , pp. 821-848
    • O'Brien, E.1    O'Brien, E.2    Asmar, R.3
  • 6
    • 33646156403 scopus 로고    scopus 로고
    • Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure
    • Mancia G., Facchetti R., Bombelli M., Grassi G., and Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 47 (2006) 846-853
    • (2006) Hypertension , vol.47 , pp. 846-853
    • Mancia, G.1    Facchetti, R.2    Bombelli, M.3    Grassi, G.4    Sega, R.5
  • 7
    • 33846037365 scopus 로고    scopus 로고
    • Detection of carotid atherosclerosis in subjects with masked hypertension and whitecoat hypertension by self-measured blood pressure at home: the Ohasama study
    • Hara A., Ohkubo T., Kikuya M., et al. Detection of carotid atherosclerosis in subjects with masked hypertension and whitecoat hypertension by self-measured blood pressure at home: the Ohasama study. J Hypertens 25 (2007) 321-327
    • (2007) J Hypertens , vol.25 , pp. 321-327
    • Hara, A.1    Ohkubo, T.2    Kikuya, M.3
  • 8
    • 33645518432 scopus 로고    scopus 로고
    • Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes
    • CAFE Investigators, Anglo-Scandinavian Cardiac Outcomes Trial Investigators, CAFE Steering Committee and Writing Committee
    • Williams B., Lacy P.S., Thom S.M., et al., CAFE Investigators, Anglo-Scandinavian Cardiac Outcomes Trial Investigators, CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Circulation 113 (2006) 1213-1225
    • (2006) Circulation , vol.113 , pp. 1213-1225
    • Williams, B.1    Lacy, P.S.2    Thom, S.M.3
  • 9
    • 34250875202 scopus 로고    scopus 로고
    • Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart study
    • Roman M.J., Devereux R.B., Kizer J.R., et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart study. Hypertension 50 (2007) 197-203
    • (2007) Hypertension , vol.50 , pp. 197-203
    • Roman, M.J.1    Devereux, R.B.2    Kizer, J.R.3
  • 10
    • 34250862170 scopus 로고    scopus 로고
    • Central blood pressure measurements and antihypertensive therapy: a consensus document
    • Agabiti-Rosei E., Mancia G., O'Rourke M.F., et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 50 (2007) 1-7
    • (2007) Hypertension , vol.50 , pp. 1-7
    • Agabiti-Rosei, E.1    Mancia, G.2    O'Rourke, M.F.3
  • 11
    • 33746011870 scopus 로고    scopus 로고
    • Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart study
    • Srinivasan S.R., Myers L., and Berenson G.S. Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart study. Hypertension 48 (2006) 33-39
    • (2006) Hypertension , vol.48 , pp. 33-39
    • Srinivasan, S.R.1    Myers, L.2    Berenson, G.S.3
  • 12
    • 33748138705 scopus 로고    scopus 로고
    • Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults
    • Grotto I., Grossman E., Huerta M., and Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension 48 (2006) 254-259
    • (2006) Hypertension , vol.48 , pp. 254-259
    • Grotto, I.1    Grossman, E.2    Huerta, M.3    Sharabi, Y.4
  • 13
    • 33747443518 scopus 로고    scopus 로고
    • Elevated blood pressure in adolescent boys predicts endothelial dysfunction: The Cardiovascular Risk in Young Finns study
    • Juonala M., Viikari J.S.A., Ronnemaa T., et al. Elevated blood pressure in adolescent boys predicts endothelial dysfunction: The Cardiovascular Risk in Young Finns study. Hypertension 48 (2006) 424-430
    • (2006) Hypertension , vol.48 , pp. 424-430
    • Juonala, M.1    Viikari, J.S.A.2    Ronnemaa, T.3
  • 14
    • 33745991122 scopus 로고    scopus 로고
    • Effects of childhood primary hypertension on carotid intima-media thickness: a matched controlled study
    • Lande M.B., Carson N.L., Roy J., and Meagher C.C. Effects of childhood primary hypertension on carotid intima-media thickness: a matched controlled study. Hypertension 48 (2006) 40-44
    • (2006) Hypertension , vol.48 , pp. 40-44
    • Lande, M.B.1    Carson, N.L.2    Roy, J.3    Meagher, C.C.4
  • 15
    • 33846257200 scopus 로고    scopus 로고
    • Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults. The Strong Heart study
    • Drukteinis J., Roman M.J., Fabsitz R.R., et al. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults. The Strong Heart study. Circulation 115 (2007) 221-227
    • (2007) Circulation , vol.115 , pp. 221-227
    • Drukteinis, J.1    Roman, M.J.2    Fabsitz, R.R.3
  • 16
    • 33847131495 scopus 로고    scopus 로고
    • Prehypertension and Cardiovascular Disease Risk in the Women's Health Initiative
    • Women's Health Initiative Investigators
    • Hsia J., Margolis K.L., Eaton C.B., et al., Women's Health Initiative Investigators. Prehypertension and Cardiovascular Disease Risk in the Women's Health Initiative. Circulation 115 (2007) 855-860
    • (2007) Circulation , vol.115 , pp. 855-860
    • Hsia, J.1    Margolis, K.L.2    Eaton, C.B.3
  • 17
    • 33644975021 scopus 로고    scopus 로고
    • Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart study
    • Zhang Y., Lee E.T., Devereux R.B., et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart study. Hypertension 47 (2006) 410-414
    • (2006) Hypertension , vol.47 , pp. 410-414
    • Zhang, Y.1    Lee, E.T.2    Devereux, R.B.3
  • 18
    • 34547927560 scopus 로고    scopus 로고
    • Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities-the DETECTIV pilot study
    • Duprez D.A., Florea N.D., Jones K., and Cohn J.N. Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities-the DETECTIV pilot study. J Am Coll Cardiol 50 (2007) 835-839
    • (2007) J Am Coll Cardiol , vol.50 , pp. 835-839
    • Duprez, D.A.1    Florea, N.D.2    Jones, K.3    Cohn, J.N.4
  • 19
    • 34547944358 scopus 로고    scopus 로고
    • Hypertension in the young-preventing the evolution of disease versus prevention of clinical events
    • Williams B. Hypertension in the young-preventing the evolution of disease versus prevention of clinical events. J Am Coll Cardiol 50 (2007) 840-842
    • (2007) J Am Coll Cardiol , vol.50 , pp. 840-842
    • Williams, B.1
  • 20
    • 0035814950 scopus 로고    scopus 로고
    • Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus
    • Rizzoni D., Porteri E., Guelfi D., et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 103 (2001) 1238-1244
    • (2001) Circulation , vol.103 , pp. 1238-1244
    • Rizzoni, D.1    Porteri, E.2    Guelfi, D.3
  • 21
    • 34147108837 scopus 로고    scopus 로고
    • Small artery structure is an independent predictor of cardiovascular events in essential hypertension
    • Mathiassen O.N., Buus N.H., Sihm I., et al. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 25 (2007) 1021-1026
    • (2007) J Hypertens , vol.25 , pp. 1021-1026
    • Mathiassen, O.N.1    Buus, N.H.2    Sihm, I.3
  • 22
    • 33846857345 scopus 로고    scopus 로고
    • Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function
    • Erdogan D., Yildirim I., Ciftci O., et al. Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 115 (2007) 593-599
    • (2007) Circulation , vol.115 , pp. 593-599
    • Erdogan, D.1    Yildirim, I.2    Ciftci, O.3
  • 23
    • 33646138248 scopus 로고    scopus 로고
    • Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke
    • Witt N., Wong T.Y., Hughes A.D., et al. Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension 47 (2006) 975-981
    • (2006) Hypertension , vol.47 , pp. 975-981
    • Witt, N.1    Wong, T.Y.2    Hughes, A.D.3
  • 24
    • 33845367538 scopus 로고    scopus 로고
    • Arterial stiffness and progression to hypertension in Japanese male subjects with high normal blood pressure
    • Yambe M., Tomiyama H., Yamada J., et al. Arterial stiffness and progression to hypertension in Japanese male subjects with high normal blood pressure. J Hypertens 24 (2007) 87-93
    • (2007) J Hypertens , vol.24 , pp. 87-93
    • Yambe, M.1    Tomiyama, H.2    Yamada, J.3
  • 25
    • 33947100948 scopus 로고    scopus 로고
    • Estimate of white-coat effect and arterial stiffness
    • de Simone G., Schillaci G., Chinali M., et al. Estimate of white-coat effect and arterial stiffness. J Hypertens 25 (2007) 827-831
    • (2007) J Hypertens , vol.25 , pp. 827-831
    • de Simone, G.1    Schillaci, G.2    Chinali, M.3
  • 26
    • 33747411832 scopus 로고    scopus 로고
    • Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension
    • Leoncini G., Ratto E., Viazzi F., et al. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension 48 (2006) 397-403
    • (2006) Hypertension , vol.48 , pp. 397-403
    • Leoncini, G.1    Ratto, E.2    Viazzi, F.3
  • 27
    • 34147157367 scopus 로고    scopus 로고
    • Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual
    • Scuteri A., Tesauro M., Appolloni S., et al. Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens 25 (2007) 1035-1040
    • (2007) J Hypertens , vol.25 , pp. 1035-1040
    • Scuteri, A.1    Tesauro, M.2    Appolloni, S.3
  • 28
    • 33750251476 scopus 로고    scopus 로고
    • Ambulatory arterial stiffness index predicts stroke in a general population
    • Hansen T.W., Staessen J.A., Torp-Pedersen C., et al. Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens 24 (2006) 2247-2253
    • (2006) J Hypertens , vol.24 , pp. 2247-2253
    • Hansen, T.W.1    Staessen, J.A.2    Torp-Pedersen, C.3
  • 29
    • 33644976911 scopus 로고    scopus 로고
    • Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome study
    • Dolan E., Thijs L., Li Y., et al. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome study. Hypertension 47 (2006) 365-370
    • (2006) Hypertension , vol.47 , pp. 365-370
    • Dolan, E.1    Thijs, L.2    Li, Y.3
  • 30
    • 33748547599 scopus 로고    scopus 로고
    • Ambulatory arterial stiffness index and renal abnormalities in primary hypertension
    • Ratto E., Leoncini G., Viazzi F., et al. Ambulatory arterial stiffness index and renal abnormalities in primary hypertension. J Hypertens 24 (2006) 2033-2038
    • (2006) J Hypertens , vol.24 , pp. 2033-2038
    • Ratto, E.1    Leoncini, G.2    Viazzi, F.3
  • 31
    • 33746006511 scopus 로고    scopus 로고
    • Prognostic implications of left ventricular mass among Hispanics. The Northern Manhattan study
    • Rodriguez C.J., Lin R., Sacco R.L., et al. Prognostic implications of left ventricular mass among Hispanics. The Northern Manhattan study. Hypertension 48 (2006) 87-92
    • (2006) Hypertension , vol.48 , pp. 87-92
    • Rodriguez, C.J.1    Lin, R.2    Sacco, R.L.3
  • 32
    • 33845225600 scopus 로고    scopus 로고
    • Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging. The Multiethnic Study of Atherosclerosis
    • Heckbert S.R., Post W., Pearson G.D.N., et al. Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging. The Multiethnic Study of Atherosclerosis. J Am Coll Cardiol 48 (2006) 2285-2292
    • (2006) J Am Coll Cardiol , vol.48 , pp. 2285-2292
    • Heckbert, S.R.1    Post, W.2    Pearson, G.D.N.3
  • 33
    • 34147123809 scopus 로고    scopus 로고
    • Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE study
    • Palmieri V., Okin P.M., de Simone G., et al. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 25 (2007) 1079-1085
    • (2007) J Hypertens , vol.25 , pp. 1079-1085
    • Palmieri, V.1    Okin, P.M.2    de Simone, G.3
  • 34
    • 33748536095 scopus 로고    scopus 로고
    • Impact of the time rate of blood pressure variation on left ventricular mass
    • Zakopoulos N., Tsivgoulis G.T., Barlas G., et al. Impact of the time rate of blood pressure variation on left ventricular mass. J Hypertens 24 (2006) 2071-2077
    • (2006) J Hypertens , vol.24 , pp. 2071-2077
    • Zakopoulos, N.1    Tsivgoulis, G.T.2    Barlas, G.3
  • 35
    • 33747446987 scopus 로고    scopus 로고
    • Importance of the electrocardiographic strain pattern in patients with resistant hypertension
    • Salles G., Cardoso C., Nogueira A.R., Bloch K., and Muxfeldt E. Importance of the electrocardiographic strain pattern in patients with resistant hypertension. Hypertension 48 (2006) 437-442
    • (2006) Hypertension , vol.48 , pp. 437-442
    • Salles, G.1    Cardoso, C.2    Nogueira, A.R.3    Bloch, K.4    Muxfeldt, E.5
  • 36
    • 33646123080 scopus 로고    scopus 로고
    • Electrocardiographic QRS duration and the risk of congestive heart failure-the Framingham Heart study
    • Dhingra R., Pencina M.J., Wang T.J., et al. Electrocardiographic QRS duration and the risk of congestive heart failure-the Framingham Heart study. Hypertension 47 (2006) 861-867
    • (2006) Hypertension , vol.47 , pp. 861-867
    • Dhingra, R.1    Pencina, M.J.2    Wang, T.J.3
  • 37
    • 33646152742 scopus 로고    scopus 로고
    • Longitudinal mitral annulus velocities are reduced in hypertensive subjects with or without left ventricle hypertrophy
    • Candida M., Borges C., Colombo R.C.R., et al. Longitudinal mitral annulus velocities are reduced in hypertensive subjects with or without left ventricle hypertrophy. Hypertension 47 (2006) 854-860
    • (2006) Hypertension , vol.47 , pp. 854-860
    • Candida, M.1    Borges, C.2    Colombo, R.C.R.3
  • 38
    • 34250689098 scopus 로고    scopus 로고
    • Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial
    • Valsartan In Diastolic Dysfunction (VALIDD) Investigators
    • Solomon S.D., Janardhanan R., Verma A., et al., Valsartan In Diastolic Dysfunction (VALIDD) Investigators. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 369 (2007) 2079-2087
    • (2007) Lancet , vol.369 , pp. 2079-2087
    • Solomon, S.D.1    Janardhanan, R.2    Verma, A.3
  • 39
    • 33845468432 scopus 로고    scopus 로고
    • Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure
    • Aksnes T.A., Flaa A., Strand A., and Kjeldsen S.E. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure. J Hypertens 25 (2007) 15-23
    • (2007) J Hypertens , vol.25 , pp. 15-23
    • Aksnes, T.A.1    Flaa, A.2    Strand, A.3    Kjeldsen, S.E.4
  • 40
    • 33744970899 scopus 로고    scopus 로고
    • Left atrial size physiologic determinants and clinical applications
    • Abhayaratna W.P., Seward J.B., Appleton C.P., et al. Left atrial size physiologic determinants and clinical applications. J Am Coll Cardiol 47 (2006) 2357-2363
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2357-2363
    • Abhayaratna, W.P.1    Seward, J.B.2    Appleton, C.P.3
  • 41
    • 33748662421 scopus 로고    scopus 로고
    • Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension
    • Okin P.M., Wachtell K., Devereux R.B., et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA 296 (2006) 1242-1248
    • (2006) JAMA , vol.296 , pp. 1242-1248
    • Okin, P.M.1    Wachtell, K.2    Devereux, R.B.3
  • 42
    • 34547868157 scopus 로고    scopus 로고
    • Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death
    • Wachtell K., Okin P.M., Olsen M.H., et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death. Circulation 116 (2007) 700-705
    • (2007) Circulation , vol.116 , pp. 700-705
    • Wachtell, K.1    Okin, P.M.2    Olsen, M.H.3
  • 43
    • 33750731595 scopus 로고    scopus 로고
    • Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure
    • Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296 (2006) 2217-2226
    • (2006) JAMA , vol.296 , pp. 2217-2226
    • Gheorghiade, M.1    Abraham, W.T.2    Albert, N.M.3
  • 44
    • 0344420330 scopus 로고    scopus 로고
    • Predicting mortality among patients hospitalized for heart failure
    • Lee D.S., Austin P.C., Rouleau J.L., et al. Predicting mortality among patients hospitalized for heart failure. JAMA 290 (2003) 2581-2587
    • (2003) JAMA , vol.290 , pp. 2581-2587
    • Lee, D.S.1    Austin, P.C.2    Rouleau, J.L.3
  • 45
    • 33745640708 scopus 로고    scopus 로고
    • Diurnal blood pressure pattern and risk of congestive heart failure
    • Ingelsson E., Bjorklund-Bodegard K., Lind L., and Sundstrom J. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 295 (2006) 2859-2866
    • (2006) JAMA , vol.295 , pp. 2859-2866
    • Ingelsson, E.1    Bjorklund-Bodegard, K.2    Lind, L.3    Sundstrom, J.4
  • 46
    • 41249092747 scopus 로고    scopus 로고
    • Guidelines for the early management of adults with ischemic stroke
    • Adams Jr. H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke. Circulation 115 (2007) e478-e534
    • (2007) Circulation , vol.115
    • Adams Jr., H.P.1    del Zoppo, G.2    Alberts, M.J.3
  • 47
    • 34249785974 scopus 로고    scopus 로고
    • Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update
    • Broderick J., Connolly S., Feldmann E., et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update. Stroke 38 (2007) 2001-2023
    • (2007) Stroke , vol.38 , pp. 2001-2023
    • Broderick, J.1    Connolly, S.2    Feldmann, E.3
  • 48
    • 33747186695 scopus 로고    scopus 로고
    • ADMA increases arterial stiffness and decreases cerebral blood flow in humans
    • Kielstein J.T., Donnerstag F., Gasper S., et al. ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 37 (2006) 2024-2029
    • (2006) Stroke , vol.37 , pp. 2024-2029
    • Kielstein, J.T.1    Donnerstag, F.2    Gasper, S.3
  • 49
    • 33749014907 scopus 로고    scopus 로고
    • Age-related changes in carotid artery flow and pressure pulses possible implications for cerebral microvascular disease
    • Hirata K., Yaginuma T., O'Rourke M.F., and Kawakami M. Age-related changes in carotid artery flow and pressure pulses possible implications for cerebral microvascular disease. Stroke 37 (2006) 2552-2556
    • (2006) Stroke , vol.37 , pp. 2552-2556
    • Hirata, K.1    Yaginuma, T.2    O'Rourke, M.F.3    Kawakami, M.4
  • 50
    • 33744970068 scopus 로고    scopus 로고
    • Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke
    • Willmot M., Ghadami A., Whysall B., et al. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 47 (2006) 1209-1215
    • (2006) Hypertension , vol.47 , pp. 1209-1215
    • Willmot, M.1    Ghadami, A.2    Whysall, B.3
  • 51
    • 33747405973 scopus 로고    scopus 로고
    • Blood pressure lowering for primary and secondary prevention of stroke
    • Zhang H., Thijs L., and Staessen J.A. Blood pressure lowering for primary and secondary prevention of stroke. Hypertension 48 (2006) 187-195
    • (2006) Hypertension , vol.48 , pp. 187-195
    • Zhang, H.1    Thijs, L.2    Staessen, J.A.3
  • 52
    • 33748202165 scopus 로고    scopus 로고
    • Control of hypertension 5 years after stroke in the North East Melbourne Stroke Incidence Study
    • Paul S.L., and Thrift A.G. Control of hypertension 5 years after stroke in the North East Melbourne Stroke Incidence Study. Hypertension 48 (2006) 260-265
    • (2006) Hypertension , vol.48 , pp. 260-265
    • Paul, S.L.1    Thrift, A.G.2
  • 53
    • 33646696167 scopus 로고    scopus 로고
    • Reducing the risk of dementia: efficacy of long-term treatment of hypertension
    • Peila R., White L.R., Masaki K., Petrovitch H., and Launer L.J. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke 37 (2006) 1165-1170
    • (2006) Stroke , vol.37 , pp. 1165-1170
    • Peila, R.1    White, L.R.2    Masaki, K.3    Petrovitch, H.4    Launer, L.J.5
  • 54
    • 33748543254 scopus 로고    scopus 로고
    • Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints
    • Hanon O., Pequignot R., Seux M.L., et al. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. J Hypertens 24 (2006) 2101-2107
    • (2006) J Hypertens , vol.24 , pp. 2101-2107
    • Hanon, O.1    Pequignot, R.2    Seux, M.L.3
  • 55
    • 34250345162 scopus 로고    scopus 로고
    • Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up
    • Almgren T., Wilhelmsen L., Samuelsson O., et al. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. J Hypertens 25 (2007) 1311-1317
    • (2007) J Hypertens , vol.25 , pp. 1311-1317
    • Almgren, T.1    Wilhelmsen, L.2    Samuelsson, O.3
  • 56
    • 33846294746 scopus 로고    scopus 로고
    • Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
    • Elliott W.J., and Meyer P.M. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 369 (2007) 201-207
    • (2007) Lancet , vol.369 , pp. 201-207
    • Elliott, W.J.1    Meyer, P.M.2
  • 57
    • 84969213492 scopus 로고    scopus 로고
    • Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
    • The Wellcome Trust Case Control Consortium
    • The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
    • (2007) Nature , vol.447 , pp. 661-678
  • 58
    • 34247863975 scopus 로고    scopus 로고
    • Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of trials of hypertension prevention
    • Cook N.R., Cutler J.A., Obarzanek E., et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of trials of hypertension prevention. BMJ 334 (2007) 885-892
    • (2007) BMJ , vol.334 , pp. 885-892
    • Cook, N.R.1    Cutler, J.A.2    Obarzanek, E.3
  • 59
    • 33750258444 scopus 로고    scopus 로고
    • Importance of salt in determining blood pressure in children meta-analysis of controlled trials
    • He F.J., and MacGregor G.A. Importance of salt in determining blood pressure in children meta-analysis of controlled trials. Hypertension 48 (2006) 861-869
    • (2006) Hypertension , vol.48 , pp. 861-869
    • He, F.J.1    MacGregor, G.A.2
  • 60
    • 34147178513 scopus 로고    scopus 로고
    • Alcohol consumption and blood pressure in the adult US population: assessment of gender-related effects
    • McFarlane S.I., von Gizycki H., Salifu M., et al. Alcohol consumption and blood pressure in the adult US population: assessment of gender-related effects. J Hypertens 25 (2007) 965-970
    • (2007) J Hypertens , vol.25 , pp. 965-970
    • McFarlane, S.I.1    von Gizycki, H.2    Salifu, M.3
  • 61
    • 33744981162 scopus 로고    scopus 로고
    • Alcohol and hypertension-an update
    • Beilin L.J., and Puddey I.B. Alcohol and hypertension-an update. Hypertension 47 (2006) 1035-1038
    • (2006) Hypertension , vol.47 , pp. 1035-1038
    • Beilin, L.J.1    Puddey, I.B.2
  • 62
    • 33646158689 scopus 로고    scopus 로고
    • Short sleep duration as a risk factor for hypertension: analyses of the First National Health and Nutrition Examination Survey
    • Gangwisch J.E., Heymsfield S.B., Boden-Albala B., et al. Short sleep duration as a risk factor for hypertension: analyses of the First National Health and Nutrition Examination Survey. Hypertension 47 (2006) 833-839
    • (2006) Hypertension , vol.47 , pp. 833-839
    • Gangwisch, J.E.1    Heymsfield, S.B.2    Boden-Albala, B.3
  • 63
    • 0034636477 scopus 로고    scopus 로고
    • Prospective study of the association between sleep-disordered breathing and hypertension
    • Peppard P.E., Young T., Palta M., and Sktarud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
    • (2000) N Engl J Med , vol.342 , pp. 1378-1384
    • Peppard, P.E.1    Young, T.2    Palta, M.3    Sktarud, J.4
  • 64
    • 33646164661 scopus 로고    scopus 로고
    • Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure
    • Norman D., Loredo J.S., Nelesen R.A., et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 47 (2006) 840-845
    • (2006) Hypertension , vol.47 , pp. 840-845
    • Norman, D.1    Loredo, J.S.2    Nelesen, R.A.3
  • 65
    • 33644981542 scopus 로고    scopus 로고
    • Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure
    • Ernst M.E., Carter B.L., Goerdt C.J., et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47 (2006) 352-358
    • (2006) Hypertension , vol.47 , pp. 352-358
    • Ernst, M.E.1    Carter, B.L.2    Goerdt, C.J.3
  • 66
    • 1542432170 scopus 로고    scopus 로고
    • Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society 2004-BHS IV
    • Williams B., Poulter N.R., Brown M.J., et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society 2004-BHS IV. J Hum Hypertens 18 (2004) 139-185
    • (2004) J Hum Hypertens , vol.18 , pp. 139-185
    • Williams, B.1    Poulter, N.R.2    Brown, M.J.3
  • 67
    • 34047197931 scopus 로고    scopus 로고
    • Effect of spironolactone on blood pressure in subjects with resistant hypertension
    • Anglo-Scandinavian Cardiac Outcomes Trial Investigators
    • Chapman N., Dobson J., Wilson S., et al., Anglo-Scandinavian Cardiac Outcomes Trial Investigators. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49 (2007) 839-845
    • (2007) Hypertension , vol.49 , pp. 839-845
    • Chapman, N.1    Dobson, J.2    Wilson, S.3
  • 68
    • 33947162019 scopus 로고    scopus 로고
    • Low-dose spironolactone in the management of resistant hypertension: a surveillance study
    • Lane D.A., Shah S., and Beevers D.G. Low-dose spironolactone in the management of resistant hypertension: a surveillance study. J Hypertens 25 (2007) 891-894
    • (2007) J Hypertens , vol.25 , pp. 891-894
    • Lane, D.A.1    Shah, S.2    Beevers, D.G.3
  • 69
    • 33745273601 scopus 로고    scopus 로고
    • Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension
    • Sharabi Y., Adler E., Shamis A., et al. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension. Am J Hypertens 19 (2006) 750-755
    • (2006) Am J Hypertens , vol.19 , pp. 750-755
    • Sharabi, Y.1    Adler, E.2    Shamis, A.3
  • 70
    • 33748147006 scopus 로고    scopus 로고
    • Thiazide diuretics, potassium, and the development of diabetes: a quantitative review
    • Zillich A.J., Garg J., Basu S., Bakris G.L., and Carter B.L. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 48 (2006) 219-224
    • (2006) Hypertension , vol.48 , pp. 219-224
    • Zillich, A.J.1    Garg, J.2    Basu, S.3    Bakris, G.L.4    Carter, B.L.5
  • 71
    • 33749985149 scopus 로고    scopus 로고
    • Oral renin inhibitors (erratum in: Lancet 2006;368:2124)
    • Staessen J.A., Li Y., and Richart T. Oral renin inhibitors (erratum in: Lancet 2006;368:2124). Lancet 368 (2006) 1449-1456
    • (2006) Lancet , vol.368 , pp. 1449-1456
    • Staessen, J.A.1    Li, Y.2    Richart, T.3
  • 72
    • 14844363404 scopus 로고    scopus 로고
    • Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients
    • Gradman A.H., Schmieder R.E., Lins R.L., et al. Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients. Circulation 111 (2005) 1012-1018
    • (2005) Circulation , vol.111 , pp. 1012-1018
    • Gradman, A.H.1    Schmieder, R.E.2    Lins, R.L.3
  • 73
    • 34548442794 scopus 로고    scopus 로고
    • The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskiren
    • Menard J., and Azizi M. The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskiren. J Hypertens 25 (2007) 1775-1782
    • (2007) J Hypertens , vol.25 , pp. 1775-1782
    • Menard, J.1    Azizi, M.2
  • 74
    • 34250353444 scopus 로고    scopus 로고
    • The potential role of prorenin in diabetic nephropathy
    • Schmieder R.E. The potential role of prorenin in diabetic nephropathy. J Hypertens 25 (2007) 1323-1326
    • (2007) J Hypertens , vol.25 , pp. 1323-1326
    • Schmieder, R.E.1
  • 75
    • 34447521458 scopus 로고    scopus 로고
    • Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial
    • Oparil S., Yarows S.A., Patel S., et al. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial. Lancet 370 (2007) 221-229
    • (2007) Lancet , vol.370 , pp. 221-229
    • Oparil, S.1    Yarows, S.A.2    Patel, S.3
  • 76
    • 33845362874 scopus 로고    scopus 로고
    • A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity
    • Ambuhl P.M., Tissot A.C., Fulurija A., et al. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. J Hypertens 25 (2007) 63-72
    • (2007) J Hypertens , vol.25 , pp. 63-72
    • Ambuhl, P.M.1    Tissot, A.C.2    Fulurija, A.3
  • 77
    • 33845372028 scopus 로고    scopus 로고
    • A vaccine for hypertension?
    • Menard J. A vaccine for hypertension?. J Hypertens 25 (2007) 41-46
    • (2007) J Hypertens , vol.25 , pp. 41-46
    • Menard, J.1
  • 78
    • 33750257495 scopus 로고    scopus 로고
    • Stop Hypertension With Acupuncture Research (SHARP)
    • Macklin E.A., Wayne P.M., Kalish L.A., et al. Stop Hypertension With Acupuncture Research (SHARP). Hypertension 48 (2006) 838-845
    • (2006) Hypertension , vol.48 , pp. 838-845
    • Macklin, E.A.1    Wayne, P.M.2    Kalish, L.A.3
  • 79
    • 34250695966 scopus 로고    scopus 로고
    • Randomized trial of acupuncture to lower blood pressure
    • Flachskampf F.A., Gallasch J., Gefeller O., et al. Randomized trial of acupuncture to lower blood pressure. Circulation 115 (2007) 3121-3129
    • (2007) Circulation , vol.115 , pp. 3121-3129
    • Flachskampf, F.A.1    Gallasch, J.2    Gefeller, O.3
  • 80
    • 33750242986 scopus 로고    scopus 로고
    • Soluble guanylate cyclase stimulation on cardiovascular remodeling in angiotensin II-induced hypertensive rats
    • Masuyama H., Tsuruda T., Kato J., et al. Soluble guanylate cyclase stimulation on cardiovascular remodeling in angiotensin II-induced hypertensive rats. Hypertension 48 (2006) 972-978
    • (2006) Hypertension , vol.48 , pp. 972-978
    • Masuyama, H.1    Tsuruda, T.2    Kato, J.3
  • 81
    • 10644246127 scopus 로고    scopus 로고
    • Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process
    • Bakris G.L., Bank A.J., Kass D.A., et al. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process. Am J Hypertens 17 (2004) 23S-30S
    • (2004) Am J Hypertens , vol.17
    • Bakris, G.L.1    Bank, A.J.2    Kass, D.A.3
  • 82
    • 33846849277 scopus 로고    scopus 로고
    • Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension
    • Zieman S.J., Melenovsky V., Clattenburg L., et al. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens 25 (2007) 577-583
    • (2007) J Hypertens , vol.25 , pp. 577-583
    • Zieman, S.J.1    Melenovsky, V.2    Clattenburg, L.3
  • 83
    • 0028296142 scopus 로고
    • Progression of aortic dilatation and the benefit of long term beta-adrenergic blockade in Marfan's syndrome
    • Shores J., Berger K.R., Murphy E.A., and Pyeritz R.E. Progression of aortic dilatation and the benefit of long term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 330 (1994) 1335-1341
    • (1994) N Engl J Med , vol.330 , pp. 1335-1341
    • Shores, J.1    Berger, K.R.2    Murphy, E.A.3    Pyeritz, R.E.4
  • 84
    • 33645672459 scopus 로고    scopus 로고
    • Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome
    • Habashi J.P., Judge D.P., Holm T.M., et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (2006) 117-121
    • (2006) Science , vol.312 , pp. 117-121
    • Habashi, J.P.1    Judge, D.P.2    Holm, T.M.3
  • 85
    • 34948849376 scopus 로고    scopus 로고
    • Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome-a randomized controlled trial
    • Ahimastos A.A., Aggarwal A., D'Orsa K.M., et al. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome-a randomized controlled trial. JAMA 298 (2007) 1539-1547
    • (2007) JAMA , vol.298 , pp. 1539-1547
    • Ahimastos, A.A.1    Aggarwal, A.2    D'Orsa, K.M.3
  • 86
    • 34548775221 scopus 로고    scopus 로고
    • Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome
    • Lacro R.V., Dietz H.C., Wruck L.M., et al. Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J 154 (2007) 624-631
    • (2007) Am Heart J , vol.154 , pp. 624-631
    • Lacro, R.V.1    Dietz, H.C.2    Wruck, L.M.3
  • 87
    • 33846406043 scopus 로고    scopus 로고
    • Low-dose quadruple antihypertensive combination more efficacious than individual agents-a preliminary report
    • Mahmud A., and Feely J. Low-dose quadruple antihypertensive combination more efficacious than individual agents-a preliminary report. Hypertension 49 (2007) 272-275
    • (2007) Hypertension , vol.49 , pp. 272-275
    • Mahmud, A.1    Feely, J.2
  • 88
    • 33845450660 scopus 로고    scopus 로고
    • Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial
    • Lee J.K., Grace K.A., and Taylor A.J. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 296 (2006) 2563-2571
    • (2006) JAMA , vol.296 , pp. 2563-2571
    • Lee, J.K.1    Grace, K.A.2    Taylor, A.J.3
  • 89
    • 34047238791 scopus 로고    scopus 로고
    • Do statins reduce blood pressure?. A meta-analysis of randomized, controlled trials
    • Strazzullo P., Kerry S.M., Barbato A., et al. Do statins reduce blood pressure?. A meta-analysis of randomized, controlled trials. Hypertension 49 (2007) 792-798
    • (2007) Hypertension , vol.49 , pp. 792-798
    • Strazzullo, P.1    Kerry, S.M.2    Barbato, A.3
  • 90
    • 0034799888 scopus 로고    scopus 로고
    • The Conduit Artery Functional Endpoint (CAFE) study in ASCOT
    • Williams B., and O'Rourke M. The Conduit Artery Functional Endpoint (CAFE) study in ASCOT. J Hum Hypertens 15 Suppl 1 (2001) S69-S73
    • (2001) J Hum Hypertens , vol.15 , Issue.SUPPL. 1
    • Williams, B.1    O'Rourke, M.2
  • 91
    • 34247379373 scopus 로고    scopus 로고
    • Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study
    • Jikei Heart Study group
    • Mochizuki S., Dahlöf B., Shimizu M., et al., Jikei Heart Study group. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 369 (2007) 1431-1439
    • (2007) Lancet , vol.369 , pp. 1431-1439
    • Mochizuki, S.1    Dahlöf, B.2    Shimizu, M.3
  • 92
    • 2942635317 scopus 로고    scopus 로고
    • Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
    • Julius S., Kjeldsen S.E., Weber M., et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 363 (2004) 2022-2031
    • (2004) Lancet , vol.363 , pp. 2022-2031
    • Julius, S.1    Kjeldsen, S.E.2    Weber, M.3
  • 93
    • 33747434821 scopus 로고    scopus 로고
    • The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy
    • Julius S., Weber M.A., Kjeldsen S.E., et al. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy. Hypertension 48 (2006) 385-391
    • (2006) Hypertension , vol.48 , pp. 385-391
    • Julius, S.1    Weber, M.A.2    Kjeldsen, S.E.3
  • 94
    • 33747382766 scopus 로고    scopus 로고
    • Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    • Leenen F.H.H., Nwachuku C.E., Black H.R., et al. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Hypertension 48 (2006) 1-11
    • (2006) Hypertension , vol.48 , pp. 1-11
    • Leenen, F.H.H.1    Nwachuku, C.E.2    Black, H.R.3
  • 95
    • 34548420712 scopus 로고    scopus 로고
    • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
    • ADVANCE Collaborative Group
    • ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 370 (2007) 829-840
    • (2007) Lancet , vol.370 , pp. 829-840
  • 96
    • 37149049924 scopus 로고    scopus 로고
    • Pharmacological management of hypertension
    • Guideline Development Group
    • Higgens B., Williams B., and Guideline Development Group. Pharmacological management of hypertension. Clin Med 7 (2007) 612-616
    • (2007) Clin Med , vol.7 , pp. 612-616
    • Higgens, B.1    Williams, B.2
  • 97
    • 33745334999 scopus 로고    scopus 로고
    • Evolution of hypertensive disease: a revolution in guidelines
    • Williams B. Evolution of hypertensive disease: a revolution in guidelines. Lancet 368 (2006) 6-7
    • (2006) Lancet , vol.368 , pp. 6-7
    • Williams, B.1
  • 99
    • 34547637288 scopus 로고    scopus 로고
    • Cardiovascular protection using beta-blockers: a critical review of the evidence
    • Bangalore S., Messerli F.H., Kostis J.B., and Pepine C.J. Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol 50 (2007) 563-572
    • (2007) J Am Coll Cardiol , vol.50 , pp. 563-572
    • Bangalore, S.1    Messerli, F.H.2    Kostis, J.B.3    Pepine, C.J.4
  • 100
    • 34250335186 scopus 로고    scopus 로고
    • Beta-blockers and the treatment of hypertension
    • Williams B. Beta-blockers and the treatment of hypertension. J Hypertens 25 (2007) 1351-1353
    • (2007) J Hypertens , vol.25 , pp. 1351-1353
    • Williams, B.1
  • 101
    • 33750233738 scopus 로고    scopus 로고
    • Beta blockers in primary hypertension: do age and type of beta-blocker matter?
    • Lindholm L.H., Carlberg B., and Samuelsson O. Beta blockers in primary hypertension: do age and type of beta-blocker matter?. J Hypertens 24 (2006) 2143-2145
    • (2006) J Hypertens , vol.24 , pp. 2143-2145
    • Lindholm, L.H.1    Carlberg, B.2    Samuelsson, O.3
  • 102
    • 34247277749 scopus 로고    scopus 로고
    • The obese hypertensive: the weight of evidence against beta-blockers
    • Williams B. The obese hypertensive: the weight of evidence against beta-blockers. Circulation 115 (2007) 1973-1974
    • (2007) Circulation , vol.115 , pp. 1973-1974
    • Williams, B.1
  • 103
    • 34247222737 scopus 로고    scopus 로고
    • Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study
    • Scholze J., Grimm E., Herrmann D., Unger T., and Kintscher U. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. Circulation 115 (2007) 1991-1998
    • (2007) Circulation , vol.115 , pp. 1991-1998
    • Scholze, J.1    Grimm, E.2    Herrmann, D.3    Unger, T.4    Kintscher, U.5
  • 104
    • 34250350040 scopus 로고    scopus 로고
    • 2007 guidelines for the management of arterial hypertension
    • The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    • The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 guidelines for the management of arterial hypertension. J Hypertens 25 (2007) 1105-1187
    • (2007) J Hypertens , vol.25 , pp. 1105-1187
  • 105
    • 34447314994 scopus 로고    scopus 로고
    • World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries
    • Mendis S., Lindholm L.H., Mancia G., et al. World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. J Hypertens 25 (2007) 1578-1582
    • (2007) J Hypertens , vol.25 , pp. 1578-1582
    • Mendis, S.1    Lindholm, L.H.2    Mancia, G.3
  • 106
    • 34249655660 scopus 로고    scopus 로고
    • Treatment of hypertension in the prevention and management of ischemic heart disease. A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
    • Rosendorff C., Black H.R., Cannon C.P., et al. Treatment of hypertension in the prevention and management of ischemic heart disease. A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 115 (2007) 2761-2788
    • (2007) Circulation , vol.115 , pp. 2761-2788
    • Rosendorff, C.1    Black, H.R.2    Cannon, C.P.3
  • 107
    • 33747437639 scopus 로고    scopus 로고
    • Controversial treatment of atherosclerotic renal vascular disease
    • Dworkin L.D. Controversial treatment of atherosclerotic renal vascular disease. Hypertension 48 (2006) 350-356
    • (2006) Hypertension , vol.48 , pp. 350-356
    • Dworkin, L.D.1
  • 108
    • 33847109796 scopus 로고    scopus 로고
    • Chronic hypertension in pregnancy
    • Seely E.W., and Maxwell C. Chronic hypertension in pregnancy. Circulation 115 (2007) e188-e190
    • (2007) Circulation , vol.115
    • Seely, E.W.1    Maxwell, C.2
  • 109
    • 34548066571 scopus 로고    scopus 로고
    • Isolated systolic hypertension in the elderly
    • Chobanian A.V. Isolated systolic hypertension in the elderly. N Engl J Med 357 (2007) 789-796
    • (2007) N Engl J Med , vol.357 , pp. 789-796
    • Chobanian, A.V.1
  • 111
    • 34250313144 scopus 로고    scopus 로고
    • Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients
    • Vaclavi{dotless}k J., Stejskal D., Lacnak B., et al. Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J Hypertension 25 (2007) 1427-1431
    • (2007) J Hypertension , vol.25 , pp. 1427-1431
    • Vaclavik, J.1    Stejskal, D.2    Lacnak, B.3
  • 112
    • 33746777182 scopus 로고    scopus 로고
    • The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults
    • Wilson S.L., and Poulter N.R. The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults. J Hypertension 24 (2006) 1457-1469
    • (2006) J Hypertension , vol.24 , pp. 1457-1469
    • Wilson, S.L.1    Poulter, N.R.2
  • 113
    • 34147127615 scopus 로고    scopus 로고
    • The sympathetic nervous system and the metabolic syndrome
    • Mancia G., Bousquet P., Elghozi J.L., et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 25 (2007) 909-920
    • (2007) J Hypertens , vol.25 , pp. 909-920
    • Mancia, G.1    Bousquet, P.2    Elghozi, J.L.3
  • 114
    • 33846669377 scopus 로고    scopus 로고
    • The eye in hypertension
    • Wong T., and Mitchell P. The eye in hypertension. Lancet 369 (2007) 425-435
    • (2007) Lancet , vol.369 , pp. 425-435
    • Wong, T.1    Mitchell, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.